Akerna Corp. (KERN) Stock Analysis

Akerna Corp. (KERN) Healthcare & Pipeline Overview

Akerna Corp. delivers regulatory compliance and inventory management software solutions for the cannabis, hemp, and CBD industries. Its MJ Platform and Leaf Data Systems offer seed-to-sale tracking and reporting, positioning it as a key enabler for businesses navigating complex regulatory landscapes in the burgeoning cannabis market.

What Is the Investment Thesis for KERN?

Akerna Corp. operates in the rapidly growing cannabis industry, providing essential software solutions for regulatory compliance and inventory management. The increasing legalization of cannabis in various states and countries presents a significant growth opportunity for the company. Akerna's MJ Platform and Leaf Data Systems are critical for businesses navigating complex regulatory frameworks. However, the company's negative profit margin of -63.4% raises concerns about its financial sustainability. Future catalysts include further cannabis legalization and expansion into new markets. Investors should closely monitor Akerna's ability to improve profitability and capitalize on the growing demand for compliance solutions in the cannabis industry.

Based on FMP financials and quantitative analysis

KERN Key Highlights

Akerna Corp. operates in the rapidly expanding cannabis software market, driven by increasing legalization and demand for compliance solutions.

• The company's MJ Platform and Leaf Data Systems provide essential tracking, reporting, and compliance tools for cannabis businesses and regulatory bodies.
• Akerna's gross margin of 52.9% indicates a strong ability to generate revenue from its software offerings.
• The company's beta of 2.79 suggests high volatility compared to the overall market.
• Akerna's negative profit margin of -63.4% highlights the need for improved cost management and revenue generation.

Who Are KERN's Competitors?

KERN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are KERN's Key Strengths?

Comprehensive software solutions for the cannabis industry

• Established customer base
• Expertise in cannabis regulations

What Are KERN's Weaknesses?

Negative profit margin

• High beta indicating high volatility
• Limited financial resources

What Could Drive KERN Stock Higher?

Further legalization of cannabis in additional states and countries, expanding Akerna's potential market.

• Increasing demand for regulatory compliance and inventory management solutions in the cannabis industry.
• Development of new software solutions and enhancements to existing products.

What Are the Key Risks for KERN?

Financial-distress signal — its Altman Z-Score of -0.48 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-16.6%) — the business is not currently generating profit on shareholder capital.
• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Increasing competition from other software providers in the cannabis industry.
• Evolving regulations that could impact the demand for Akerna's software solutions.
• Economic downturn that could reduce spending on software and consulting services.
• Akerna's negative profit margin raises concerns about its financial sustainability.

What Are the Growth Opportunities for KERN?

• Expansion into New Geographic Markets: As more states and countries legalize cannabis, Akerna has the opportunity to expand its market reach and offer its software solutions to new customers. The global cannabis market is projected to reach $57 billion by 2027, presenting a significant growth opportunity for Akerna. Successfully entering new markets requires adapting to local regulations and building relationships with key stakeholders.
• Development of New Software Solutions: Akerna can expand its product offerings by developing new software solutions that address emerging needs in the cannabis industry. This could include solutions for supply chain management, customer relationship management (CRM), or data analytics. The market for cannabis software is expected to grow rapidly in the coming years, driven by the increasing complexity of the industry.
• Partnerships and Acquisitions: Akerna can accelerate its growth by forming strategic partnerships with other companies in the cannabis industry or acquiring complementary businesses. This could provide access to new markets, technologies, or customers. Potential partners include cannabis cultivators, processors, retailers, and regulatory bodies.
• Enhancement of Existing Products: Akerna can improve its existing software solutions by adding new features and functionality. This could include enhancements to the MJ Platform, such as improved reporting capabilities, enhanced security features, or integration with other software systems. Continuous product improvement is essential for maintaining a competitive edge in the rapidly evolving cannabis software market.
• Data Analytics and Business Intelligence: Akerna can leverage its data analytics capabilities to provide valuable insights to its customers. This could include providing data on market trends, consumer behavior, and operational efficiency. The market for cannabis data analytics is growing rapidly, driven by the increasing demand for data-driven decision-making in the industry.

What Are KERN's Competitive Advantages?

• Regulatory Expertise: Akerna's deep understanding of cannabis regulations provides a competitive advantage.
• Established Customer Base: The company has an established customer base in the cannabis industry.
• Comprehensive Software Solutions: Akerna offers a comprehensive suite of software solutions for the cannabis industry.

What Does KERN Do?

Founded in 2010 and headquartered in Denver, Colorado, Akerna Corp. has established itself as a provider of enterprise software solutions tailored for the cannabis, hemp, and CBD industries. The company's core offering is the MJ Platform, a comprehensive software suite designed to enable regulatory compliance and streamline inventory management for businesses operating in these sectors. This platform provides tracking, reporting, and compliance tools essential for cultivators, processors, sellers, and clinics. Akerna also offers Leaf Data Systems, a government regulatory software used by state and local agencies to monitor and regulate the cannabis industry. Beyond its core platforms, Akerna provides consulting services to cannabis businesses, offering expertise in navigating the complex regulatory landscape. The company also offers business intelligence, data analytics, and other software-related services to help businesses optimize their operations and make data-driven decisions. Additionally, Akerna provides Last Call Analytics, a tool designed for alcohol brands to analyze their retail sales data. Akerna's seed-to-sale platform offers a comprehensive suite of tools for tracking, reporting, and compliance, catering to the entire cannabis supply chain. The company's solutions are utilized across the United States and Canada, reflecting its geographic reach and market penetration.

What Products and Services Does KERN Offer?

• Provides enterprise software solutions for the cannabis, hemp, and CBD industries.
• Offers the MJ Platform for regulatory compliance and inventory management.
• Develops Leaf Data Systems, a government regulatory software.
• Provides consulting services to cannabis businesses.
• Offers business intelligence and data analytics services.
• Provides Last Call Analytics for alcohol brands to analyze retail sales data.
• Operates a seed-to-sale platform for tracking, reporting, and compliance.

How Does KERN Make Money?

• Software as a Service (SaaS): Akerna generates revenue through subscription fees for its software platforms, such as MJ Platform and Leaf Data Systems.
• Consulting Services: The company provides consulting services to cannabis businesses, generating revenue through project-based fees.
• Data Analytics: Akerna offers data analytics services, generating revenue through subscription or usage-based fees.

What Industry Does KERN Operate In?

Akerna Corp. operates within the healthcare information services sector, specifically targeting the cannabis industry. The cannabis market is experiencing rapid growth due to increasing legalization and changing consumer attitudes. This growth is driving demand for software solutions that enable regulatory compliance, inventory management, and data analytics. Akerna competes with other software providers offering similar solutions, as well as companies providing broader enterprise resource planning (ERP) systems. The industry is characterized by evolving regulations and increasing competition, requiring companies to adapt and innovate to maintain their market position.

Who Are KERN's Key Customers?

• Cannabis cultivators
• Cannabis processors
• Cannabis retailers
• Government regulatory bodies

Company Profile

Akerna Corp. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Denver, US. The company is led by CEO Jessica Billingsley. KERN has traded publicly since 2018.

Return on equity for Akerna Corp. stands at -16.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -6.1%, showing how much profit it generates from its asset base. A current ratio of 0.13 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -25.1%, the inverse of the P/E and a quick read on earnings relative to price.

Akerna Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.48 places it in the distress zone, a signal of elevated financial risk.

The most recent 11 insider filings for Akerna Corp. break down as 6 sales and 5 purchases. On net that is roughly 3K shares disposed (about $0), a signal worth weighing alongside the fundamentals.

KERN Financials

KERN Latest News

Common Questions About KERN (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources